CYP2D6 is a drug-metabolizing enzyme responsible for processing many medications (e.g., antidepressants, opioids). There is no validated scientific link between CYP2D6 variants and general fatigue in healthy individuals. Claiming that a CYP2D6 genetic test can explain 'fatigue' is misleading and closer to marketing than evidence. Fatigue is multifactorial: sleep quality, stress, diet, exercise, hormones, and psychological factors play far larger roles than a single enzyme. In pharmacogenetics, CYP2D6 can be relevant if someone is taking drugs metabolized via this pathway – for example, to understand side effects like sedation. Without a medication context, the test is not useful for fatigue. The provided context contains no studies on CYP2D6 and fatigue. Evidence: unclear, leaning marketing. Caveat: No direct clinical relevance for general tiredness.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-b6207db01f6fb786bcb9bd73